US$ 24.40
ahk-cu x49 100mg (RUO) – Tide Labs AHK-CU Peptide - 20 mg
Description
This minimum requirement becomes the de facto standard

10.1021/acs.biochem.6b00733 148 Van HarenM

As of June 2026, the FDA's December 2024 Pharmacy Compounding Advisory Committee evaluation concluded that the criteria weighed against placing AOD-9604 (free base) or AOD-9604 acetate on the 503A Bulks List, and AOD-9604 is currently listed as Nominated but Withdrawn from FDA Category 2

Research applications include obesity, metabolic syndrome, and adipocyte biology

Key Findings: Oral cobalamin supplementation can be an effective alternative to parenteral injections

16 BubenekS.NastaseA.NiculescuA